Advertisement

Topics

Poxel SAS Company Profile

19:16 EDT 21st September 2017 | BioPortfolio

Poxel is a new RIPCO that aims to advance promising assets for cardio-metabolic diseases from Research to Phase 2 Clinical Proof of Concept, before out licensing projects to pharmaceutical companies. Poxel will further develop its portfolio by considering all opportunities corresponding to its core domain of competencies.


News Articles [35 Associated News Articles listed on BioPortfolio]

Poxel To Present New Preclinical Imeglimin Data On Protective Benefits From Diabetic Cardiomyopathy At American Diabetes Association Meeting

LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including...

Imeglimin Phase IIb study in Japan for type 2 diabetes meets endpoint

French diabetes focused biotech firm Poxel (Euronext: POXEL) today announced additional results from…

Poxel to Present Results for Imeglimin Phase 2b Study in Japan for the Treatment of Type 2 Diabetes at the European Association for the Study of Diabetes 53rd Annual Meeting

Wednesday, September 6th 2017 at 6:00am UTC Lyon, FRANCE–(BUSINESS WIRE)– POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of inno...

Poxel Presents New Preclinical Imeglimin Data Demonstrating Improvement of Both Peripheral and Coronary Vascular Function at the European Society of Cardiology Congress

Monday, August 28th 2017 at 6:00am UTC Additional data from metabolic syndrome model support protective effects of Imeglimin on diabetic cardiomyopathy, a significant cardiovascular complication in di...

Poxel’s diabetes drug Imeglimin succeeds in phase 2b study in Japan

Poxel has announced positive top line results of a Phase 2b trial of Imeglimin for type 2 diabetes treatment in Japan.

Poxel reports top-line results from Phase IIb trial of imeglimin in Japan

French biopharmaceutical firm Poxel has reported positive top-line results from its Phase IIb clinical trial of imeglimin in Japan to treat patients with type 2 diabetes.

Poxel Announces Participation in Two Upcoming Investor Conferences in June

POXEL S.A. (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes,...

Poxel reports positive phase 2b study results of Imeglimin for type 2 diabetes treatment

Poxel SA, a biopharmaceutical company, has announced positive top line phase 2b data results for Imeglimin for the treatment of type 2 diabetes in Japan.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Poxel SAS

Poxel is a new RIPCO that aims to advance promising assets for cardio-metabolic diseases from Research to Phase 2 Clinical Proof of Concept, before out licensing projects to pharmaceutical compani...

More Information about "Poxel SAS" on BioPortfolio

We have published hundreds of Poxel SAS news stories on BioPortfolio along with dozens of Poxel SAS Clinical Trials and PubMed Articles about Poxel SAS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Poxel SAS Companies in our database. You can also find out about relevant Poxel SAS Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record